Beta‐blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation

A preclinical study demonstrated anti‐proliferative and apoptotic effect of propranolol on multiple myeloma (MM) cell. Clinical studies suggested that beta‐blocker (BB) might impact the prognosis of breast, prostate, colorectal, ovarian, lung, and skin cancer. This retrospective study evaluated the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Hematol
Autors principals: Hwa, Yi L., Shi, Qian, Kumar, Shaji K., Lacy, Martha Q., Gertz, Morie A., Kapoor, Prashant, Buadi, Francis K., Leung, Nelson, Dingli, David, Go, Ronald S., Hayman, Suzanne R., Gonsalves, Wilson I., Russell, Stephen, Lust, John A., Lin, Yi, Rajkumar, S. Vincent, Dispenzieri, Angela
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2016
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217079/
https://ncbi.nlm.nih.gov/pubmed/27733010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24582
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars